期刊文献+

质子磁共振波谱在帕金森病大鼠模型中的应用研究 被引量:2

Proton magnetic resonance spectroscopic changes in the striatum in rat model of Parkinson's disease
下载PDF
导出
摘要 目的:探讨质子磁共振波谱(1H-MRS)在帕金森病(PD)大鼠模型纹状体内的变化及在PD大鼠模型中的应用。方法:选用雄性Wistar大鼠12只,向其右侧纹状体内两点注射6-羟基多巴(6-OHDA)制作PD大鼠模型,5周后颈部皮下注射阿朴吗啡诱导其向健侧旋转,每分钟大于7圈者为成功模型,获6只。对照组6只大鼠以同样方法注射等剂量的生理盐水。利用BIOSPEC47/30核磁共振仪(4.7T)对双侧纹状体行1H-磁共振波谱检测,检测后立即处死动物并行黑质及纹状体酪氨酸羟化酶(TH)免疫组织化学染色。结果:模型组大鼠右侧黑质致密部TH阳性神经元及纹状体TH阳性纤维明显减少(P<0.01),证明模型制作成功。模型组大鼠右侧(毁损侧)纹状体内NAA/Cr比值明显低于左侧及对照组的两侧(P<0.05),对照组两侧NAA/Cr比值无显著差别。两组大鼠双侧纹状体内Cho/Cr比值均无显著差别。结论:1H-MRS可以作为一种无创性的新技术,为偏侧大鼠PD模型纹状体部位的神经细胞的病理学改变提供有价值的信息。 Objective: To explore the applied value of ^1H-magnetic resonance spectroscopy (^1H-MRS)in rat model of Parkinson^s disease (PD). Methods: 12 Wistar rats were divided into model and control groups. On the 5th week, after 6-hydroxydopamine injected into right striatum, ^1H-MRS on the striatum was taken and then tyrosine hydroxylase(TH) immunostatining was used to observe the changes of the neurons and neuritis in substantia nigra and striatum. Results: TH positive neurons and neurites in the right substantia nigra compacta (SNc) and striatum of the rat model of PD were decreased (P〈0.01), which proved successful PD models. The NAA/Cr ratio in the right striatum of model group was lower than that of the left side and the both sides of control group(P〈0.05). While there was no difference between the two sides in the control group (P〉0.05). The radio of Cho/Cr showed no difference between the two groups (P〉0.05). Conclusion: ^1H-MRS is a noninvasive technique that can provide useful information concerning the pathological changes of nerve cells in the striatum of PD rat models. It is a helpful method for the PD study in rat model.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第9期769-772,共4页 Journal of Shandong University:Health Sciences
基金 国家教育部高等学校博士学科点专项科研基金资助项目(20040422040)
关键词 帕金森病 大鼠 Wistar ^1H-磁共振波谱 酪氨酸单氧化酶 免疫组织化学 疾病模型 动物 Parkinson's disease Rat, Wistar ^1H-magnetic resonance spectroscopy Tyrosine hydroxylase Immunohistochemistry Disease models, animal
  • 相关文献

参考文献4

二级参考文献30

  • 1王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 2Martin WR. Magnetic resonance imaging and spectroscopy in Parkinson's disease[J].Adv Neurol, 2001, 86(1): 197-203.
  • 3Lucetti C, Del Dotto P, Gambaccini G, et al. Proton magnetic resonance spectroscopy (1 H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients[J].Neurol Sci, 2001, 22(1): 69-70.
  • 4Brownell AL, Jenkins BG, Elmaleh DR, et al. Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson' disease[J].Nat Med, 1998, 4(11): 1308-1312.
  • 5Clarke CE, Lowry M. Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes[J].Eur J Neurol, 2001, 8(6): 573-577.
  • 6Terakawa H, Nakamura M, Nakamori M, et al. Metabolite changes in the basal ganglia in patients with Parkinson's disease[J].Ann Neurol, 2000, 42(3): 467.
  • 7Eberling JL, Jagust WJ, Taylor S, et al. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes[J].Brain Res, 1998,805(1): 259-262.
  • 8Wichmann T, DeLong MR. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder[J].Ann N Y Acad Sci, 2003,991: 199-213.
  • 9Miller BL. A review of chemical issues in 1 H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline[J].NMR Biomed, 1991, 4(1): 47-52.
  • 10Podell M, Hadjiconstantinou M, Smith MA, et al. Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism[J].Exp Neurol, 2003,179(2):159-166.

共引文献32

同被引文献23

  • 1黄海东,邓敬兰,宦怡,杨春敏,葛雅丽,赵海涛.脑质子磁共振波谱在早期帕金森病诊断中的价值[J].实用放射学杂志,2004,20(6):486-488. 被引量:7
  • 2张晨,李昕,李尧华,陈彪,于顺.制备与鉴定导致家族性帕金森病突变蛋白质的α-突触核蛋白聚合体[J].中国临床康复,2005,9(13):39-41. 被引量:2
  • 3苗重昌,何银,史良玉.氢质子磁共振波谱对帕金森氏病的诊断价值[J].河北医学,2006,12(11):1114-1116. 被引量:3
  • 4Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease [ J ]. Neurology, 2000,54 ( 8 ) : 1596 - 602.
  • 5Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson diseases [ J ]. Arch Neurol, 2004,61 (12) : 1906 -11.
  • 6Garcia-Ayllon MS,Cauli O, Silveyra MX, et al. Brain cholinergic impairment in liver failure [ J ]. Brain, 2008,131 ( Pt ) : : 2946 - 2956.
  • 7Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol, 1968,5 ( 1 ) : 107 - 110.
  • 8HenshallDC,Clark RS,Adelson PD,et al. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology, 2000,55 ( 2 ) : 250 - 257.
  • 9Yamamoto Y,Schindler CK, Murphy BM, et al. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp Neurol, 2006,202(2) :410 -420.
  • 10Wiedenmann B, Franke WW. Identification and iocalization of synaptophysin, an intergral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles, cell, 1985, 41 (3) :1017 - 1028.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部